The Medical Science Liaison Role in Spain: A Survey Capturing the Opinion of Medical Department Professionals
- PMID: 35727535
- PMCID: PMC9211052
- DOI: 10.1007/s43441-022-00424-x
The Medical Science Liaison Role in Spain: A Survey Capturing the Opinion of Medical Department Professionals
Abstract
Background: Literature that addresses the role of Medical Science Liaison (MSL) is currently limited. To the best of our knowledge, this is the first survey in Spain that gathers opinions from professionals whose work is either in or related to the medical departments from pharmaceutical companies.
Methods: A survey delivered by the SurveyMonkey online platform was completed by 101 pharmaceutical industry professionals (medical advisor/manager, 31.7%; medical director, 26.7%; medical information, 12.9%; and MSL manager, 11.9%).
Results: The median score for the global impression of the MSL was 8.7. The collaboration goes beyond formation since 85.1% of the respondents believed that MSLs should actively collaborate in both clinical trials and investigator-initiated studies, they should have more involvement with market access (51.5%), and they play an important role in compliance (94.0%). There was a tendency toward granting MSLs more responsibilities in terms of budget (73.3%) and their participation in the elaboration of the Medical Plan (91.1%). This position was considered as a strategic partner both internally and externally (76.2%).
Conclusion: MSL is a well-known field-based profile with increasing importance and responsibilities. MSLs represent a strategic position as internal collaborators in the company, whose success relies on cross-functional work. The MSL's profile is in constant development, currently facing challenges such as adapting to remote interactions, or providing a clear definition with the best metrics to measure their performance as a non-promotional position.
Keywords: Medical Science Liaison; Opinion; Pharmaceutical industry; Spain; Survey.
© 2022. The Drug Information Association, Inc.
Conflict of interest statement
The authors of this publication have no conflict of interest to disclose. They are not speaking on behalf of their current companies or any previous companies.
Figures
References
-
- Medical Science Liaison Society. What is a Medical Science Liaison? Available from: https://www.themsls.org/what-is-an-msl. Accessed 25 Oct 2021.
-
- Chicharro A, Losada E, Marin H, et al. A survey of medical scientific liaisons in the pharmaceutical industry in Spain. J Med Market. 2017;16:4–9. doi: 10.1177/1745790417717086. - DOI
-
- Rutherford P, Smith NJ. QuintilesIMS. Medical Science Liaisons: A key to driving patient access to new therapies. 2016. https://www.iqvia.com/-/media/library/white-papers/medical-science-liais.... Accessed 25 Oct 2021.
-
- Bass JL, CM, Klinger CK. Survey of medical liaison practices Assessing practice trends across the pharmaceutical industry. Drug Inf J. 2010;44(5):535–549.
MeSH terms
LinkOut - more resources
Full Text Sources